» Articles » PMID: 19339239

Snapshot Peptidomics of the Regulated Secretory Pathway

Overview
Date 2009 Apr 3
PMID 19339239
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Neurons and endocrine cells have the regulated secretory pathway (RSP) in which precursor proteins undergo proteolytic processing by prohormone convertase (PC) 1/3 or 2 to generate bioactive peptides. Although motifs for PC-mediated processing have been described ((R/K)X(n)(R/K) where n = 0, 2, 4, or 6), actual processing sites cannot be predicted from amino acid sequences alone. We hypothesized that discovery of bioactive peptides would be facilitated by experimentally identifying signal peptide cleavage sites and processing sites. However, in vivo and in vitro peptide degradation, which is widely recognized in peptidomics, often hampers processing site determination. To obtain sequence information about peptides generated in the RSP on a large scale, we applied a brief exocytotic stimulus (2 min) to cultured endocrine cells and analyzed peptides released into supernatant using LC-MSMS. Of note, 387 of the 400 identified peptides arose from 19 precursor proteins known to be processed in the RSP, including nine peptide hormone and neuropeptide precursors, seven granin-like proteins, and three processing enzymes (PC1/3, PC2, and peptidyl-glycine alpha-amidating monooxygenase). In total, 373 peptides were informative enough to predict processing sites in that they have signal sequence cleavage sites, PC consensus sites, or monobasic cleavage sites. Several monobasic cleavage sites identified here were previously proved to be generated by PCs. Thus, our approach helps to predict processing sites of RSP precursor proteins and will expedite the identification of unknown bioactive peptides hidden in precursor sequences.

Citing Articles

What is known and unknown about the role of neuroendocrine genes and .

Stojilkovic S, Sokanovic S, Constantin S Front Endocrinol (Lausanne). 2025; 16:1531723.

PMID: 39926347 PMC: 11802530. DOI: 10.3389/fendo.2025.1531723.


Origins, Technological Advancement, and Applications of Peptidomics.

Schrader M Methods Mol Biol. 2024; 2758:3-47.

PMID: 38549006 DOI: 10.1007/978-1-0716-3646-6_1.


VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases.

Quinn J, Kandigian S, Trombetta B, Arnold S, Carlyle B Brain Commun. 2021; 3(4):fcab261.

PMID: 34778762 PMC: 8578498. DOI: 10.1093/braincomms/fcab261.


A Comparative Peptidomic Characterization of Cultured Skeletal Muscle Tissues Derived From Mice.

Wu Y, Han M, Wang Y, Gao Y, Cui X, Xu P Front Endocrinol (Lausanne). 2019; 10:741.

PMID: 31736878 PMC: 6828820. DOI: 10.3389/fendo.2019.00741.


Strategies for the Identification of Bioactive Neuropeptides in Vertebrates.

Corbiere A, Vaudry H, Chan P, Walet-Balieu M, Lecroq T, Lefebvre A Front Neurosci. 2019; 13:948.

PMID: 31619945 PMC: 6759750. DOI: 10.3389/fnins.2019.00948.


References
1.
Schrader M, Schulz-Knappe P . Peptidomics technologies for human body fluids. Trends Biotechnol. 2002; 19(10 Suppl):S55-60. DOI: 10.1016/S0167-7799(01)01800-5. View

2.
Clynen E, Baggerman G, Veelaert D, Cerstiaens A, van der Horst D, Harthoorn L . Peptidomics of the pars intercerebralis-corpus cardiacum complex of the migratory locust, Locusta migratoria. Eur J Biochem. 2001; 268(7):1929-39. DOI: 10.1046/j.1432-1327.2001.02067.x. View

3.
Zhou A, Webb G, Zhu X, Steiner D . Proteolytic processing in the secretory pathway. J Biol Chem. 1999; 274(30):20745-8. DOI: 10.1074/jbc.274.30.20745. View

4.
Che F, Lim J, Pan H, Biswas R, Fricker L . Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics. 2005; 4(9):1391-405. DOI: 10.1074/mcp.T500010-MCP200. View

5.
Falth M, Skold K, Norrman M, Svensson M, Fenyo D, Andren P . SwePep, a database designed for endogenous peptides and mass spectrometry. Mol Cell Proteomics. 2006; 5(6):998-1005. DOI: 10.1074/mcp.M500401-MCP200. View